KBC Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$88K Sell
2025
Q1
$137K Buy
2024
Q4
$190K Buy
2024
Q3
$112K Buy
2024
Q2
$80K Hold
2024
Q1
$84K Buy